Riad Kassem, Aditya K Gupta, Mary A Bamimore, Mesbah Talukder, Avner Shemer, Lee Magal, Anna Lyakhovitsky, Ralph Daniel, Baruch Kaplan, Eran Galili
Individuals with psoriatic nails often have a lower quality of life relative to their counterparts with healthy nails. Methotrexate (MTX), an anti-neoplastic agent, is a longstanding treatment option for nail psoriasis. In the current study, we compared the effects of MTX to that of a corticosteroid, namely, methylprednisolone acetate (i.e., Depo-Medrol®) across individuals with nail psoriasis. We used a cohort study design, and both agents were administered intralesionally. Outcome variables were based on the Nail Psoriasis Severity Index (NAPSI)...
2024: Skinmed